Publication | Closed Access

Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives

Neurodegenerative DiseasesAlzheimer's DiseaseNeurological DisorderClinical UtilityMedicineNeurochemical BiomarkersNeurologyNeuroscienceClinical ChemistryNeurodegenerationNeuropathologyPlasma DeterminationsHuman Neurodegenerative Patients